H.23

An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Sponsors: Rep. George Till

Location: House Committee on Health Care

Last Recorded Action: 1/7/2021 - Read First Time and referred to the Committee on Health Care

Committee Activity - Meeting Full List

Regular Session 2021-2022